Cyanoindole Derivatives as Highly Selective Dopamine D4Receptor Partial Agonists: Solid-Phase Synthesis, Binding Assays, and Functional Experiments
- 21 October 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (23) , 4563-4569
- https://doi.org/10.1021/jm0009989
Abstract
Traceless linking of diethoxymethyl (DEM)-protected 5- and 6-cyanoindoles and subsequent incorporation of phenylpiperazine derivatives led to the 2- and 3-piperazinylmethyl-substituted cyanoindoles 3a − m. Dopamine receptor binding studies on the final products 3a − m clearly indicated strong and selective recognition of the D4 subtype which is known as a promising target for the treatment of neuropsychiatric disorders. The most interesting binding properties were observed for the 2-aminomethyl-5-cyanoindoles FAUC 299 (3f) and FAUC 316 (3j) (Ki = 0.52 and 1.0 nM, respectively) when the fluoro derivative 3j proved extraordinary selectivity over D1, D2long, D2short, and D3 (>8600). To determine ligand efficacy, mitogenesis experiments were performed indicating partial agonist effects for the test compounds 3f,j (35% and 30%, when compared to the full agonist quinpirole).Keywords
This publication has 13 references indexed in Scilit:
- Dopamine D4 receptors: significance for molecular psychiatry at the millenniumMolecular Psychiatry, 1999
- Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L‐745,870 and U‐101958 at human recombinant D4.4 receptors expressed in CHO cellsBritish Journal of Pharmacology, 1999
- NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cellsEuropean Journal of Pharmacology, 1999
- Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligandsBioorganic & Medicinal Chemistry Letters, 1999
- The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D4.4 receptorBritish Journal of Pharmacology, 1998
- 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 ReceptorJournal of Medicinal Chemistry, 1996
- Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor VariantsJournal of Neurochemistry, 1995
- Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- The Use of Polymer Supports in Organic Synthesis. III. Selective Chemical Reactions on One Aldehyde Group of Symmetrical DialdehydesCanadian Journal of Chemistry, 1973